0001209191-17-023841.txt : 20170331 0001209191-17-023841.hdr.sgml : 20170331 20170331160909 ACCESSION NUMBER: 0001209191-17-023841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170329 FILED AS OF DATE: 20170331 DATE AS OF CHANGE: 20170331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17730431 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2017-03-29 4 M 0 5719 38.80 A 105054 D Common Stock 2017-03-29 4 M 0 17156 37.86 A 122210 D Common Stock 2017-03-29 4 M 0 29032 48.74 A 151242 D Common Stock 2017-03-29 4 M 0 28593 45.11 A 179835 D Common Stock 2017-03-29 4 S 0 51468 106.30 D 128367 D Common Stock 2017-03-29 4 S 0 29032 110.00 D 99335 D Common Stock 882 I 401k Stock Option (Right to Buy) 38.80 2017-03-29 4 M 0 5719 38.80 D 2021-02-02 Common Stock 5719 0 D Stock Option (Right to Buy) 37.86 2017-03-29 4 M 0 17156 37.86 D 2022-02-01 Common Stock 17156 0 D Stock Option (Right to Buy) 48.74 2017-03-29 4 M 0 29032 48.74 D 2022-07-24 Common Stock 29032 0 D Stock Option (Right to Buy) 45.11 2017-03-29 4 M 0 28593 45.11 D 2023-02-04 Common Stock 28593 0 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Fully vested. Omar White, Attorney-In-Fact 2017-03-31